Search
for
Sort by
Research 61–90 of 1000+
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Janus Kinase inhibitors in dermatology: a review
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn’s disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient
- A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Nanotechnological reprogramming of the pathological skin microenvironment in scar formation and atopic dermatitis
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
- Signal transducer and activator of transcription 5B deficiency due to a novel missense mutation in the coiled-coil domain
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Theoretical investigation on the construction of hair follicle membranes and the transdermal drug delivery mechanisms of JAK inhibitors via distinct pathways
- Dysregulation of Leukaemia Inhibitory Factor (LIF) Signalling Pathway by Supraphysiological Dose of Testosterone in Female Sprague Dawley Rats During Development of Endometrial Receptivity
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib
- Gut instinct: Using tofacitinib to treat alopecia areata in the context of comorbid inflammatory bowel disease